Cargando…
Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
BACKGROUND: Olanzapine (OLZ) is one of the most prescribed atypical antipsychotic drugs but its use is associated with unfavorable metabolic abnormalities. N-desmethyl-olanzapine (DMO), one of the OLZ metabolites by CYP1A2, has been reported to have a normalizing action on metabolic abnormalities, b...
Autores principales: | Lu, Mong-Liang, Lin, Chia-Hui, Chen, Yi-Chuan, Yang, Huai-Chih, Wu, Tzu-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669135/ https://www.ncbi.nlm.nih.gov/pubmed/23741510 http://dx.doi.org/10.1371/journal.pone.0065719 |
Ejemplares similares
-
Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia
por: Lu, Mong-Liang, et al.
Publicado: (2016) -
Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022) -
Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010) -
Teratogenicity with Olanzapine
por: Prakash, Sathya, et al.
Publicado: (2014) -
Olanzapine-induced reversible skin eruption
por: Deshmukh, Rohit P.
Publicado: (2023)